Women Health Market Share, Size, Trends, Industry Analysis Report, By Type (Surgical, Contraceptive, Critical Care, Labor & Delivery, Diagnostic, Others), By Application; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030

Women Health Market Share, Size, Trends, Industry Analysis Report, By Type (Surgical, Contraceptive, Critical Care, Labor & Delivery, Diagnostic, Others), By Application; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030

The Global Women Health Market size is expected to reach USD 58.10 billion by 2030, according to a new study by Polaris Market Research. The report “Women Health Market Share, Size, Trends, Industry Analysis Report, By Type (Surgical, Contraceptive, Critical Care, Labor & Delivery, Diagnostic, Others), By Application; By Distribution Channel; By Region; Segment Forecast, 2022 – 2030” provides detailed insight into current market dynamics and analysis of future market growth.

An imbalanced way of life, specifically in urban regions, has shot up the number of females getting suffered from atrocious health diseases and the surge in the application of abortions to avoid unplanned pregnancies. Moreover, the increased attention to R&D enterprise by major industry participants for producing innovative medicines and medical equipment are vital factors driving the development of the global female health market.

The rise in the number of females over 60+ who adopt noxious living conditions are more prone to disease, and the composition of modern therapeutics pointedly for women are the vital growth drivers of the female health market globally.

Various bodily disorders impact female health, including anemia, osteoporosis, osteoarthritis, depression, obesity, and mental stress. Thereupon, the industry evolution in the forthcoming years is expected to be increased by these growing informal diseases in the female genre.

Additionally, stretching rates of mental pressure associated with infertility, osteoarthritis, irregular menopause, and other types of illnesses are anticipated to boost the development of the female health sector during the projection period, along with several government health schemes to spread awareness related to female health issues.

Due to COVID-19, global trade uncertainty, economic fluctuations, travel restrictions, and short transit facilities created an obstruction to international commerce and shipping amidst the pandemic, the congested supply medium for female health diagnostics, and a decrease in demand during the lockdown.

Women Health Market Report Highlights

• The diagnostic tests section dominates the market in 2021 due to the increase in various health-oriented disorders in female like infertility, breast cancer, and the active spread of awareness about female health subjects.
• The hospitals and clinics section is a major contributor to the market in 2021 due to the increasing number of ovarian and breast cancer though the number of hospitalization cases proportionally increased.
• The increasing cases of chronic disease in female and the surge in the stipulation for contraceptives to prohibit unwanted pregnancies are factors projected to fuel the growth of the women’s health market.
• North America leads the women’s health market owing to the impendence of major players, ethical health insurance policies, a great level of awareness among women regarding feminine health issues, and government favorable schemes for the treatments.
• The global payers are Thermo Fisher Scientific Inc., Ltd., Koninklijke Philips N.V., Shenzhen Mindray Bio-Medical Electronics Co., Abbott, NeuroLogica Corp., GENERAL ELECTRIC, Roche Ltd, Hologic Inc., Siemens and Others.

Polaris Market Research has segmented the women health market report based on by type, application, distribution channel, and region:

Women Health, Type Outlook (Revenue – USD Billion, 2022 – 2030)

• Surgical
• Contraceptive
• Critical Care
• Labor & Delivery
• Diagnostic
• Others

Women Health, Application Outlook (Revenue – USD Billion, 2022 – 2030)

• Polycystic Ovary Syndrome (PCOS)
• Postmenopausal Osteoporosis
• Contraception
• Hormonal Infertility
• Female Infertility
• Menopause
• Endometriosis
• Other Applications

Women Health, Distribution Channel Outlook (Revenue – USD Billion, 2022 – 2030)

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Women Health, Regional Outlook (Revenue – USD Billion, 2022 – 2030)

• North America
• U.S
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Show more